| Features: |
| Caffeic acid is a polyphenol antioxidant found in coffee, fruits, vegetables, and herbs. It may have anti-inflammatory, anticancer, anti-aging, and other health benefits. -Caffeic acid phenethyl ester, the main representative component of propolis -Black chokeberry 141.14 mg/100 g F -Sunflower seed, meal 8.17 mg/100 g FW -Common sage, dried 26.40 mg/100 g FW -Ceylan cinnamon 24.20 mg/100 g FW -Nutmeg 16.30 mg/100 g FW -Dual capacity of CA to act as an antioxidant during carcinogenesis and as a pro-oxidant against cancer cells, promoting their apoptosis or sensitizing them to chemotherapeutic drugs. Pathways: -Caffeic acid is a potent antioxidant -Caffeic acid may also exhibit pro-oxidant behavior. At higher concentrations( 50–100 µM ?) or/and in the presence of transition metal ions (such as copper or iron), caffeic acid cab participate in Fenton-like reactions, potentially leading to increased ROS generation. -Shown to inhibit NF-κB activation -Inhibitory effects on MAPK/ERK Pathway -PI3K/Akt Signaling Pathway -Activation of the Nrf2/ARE pathway -Cell cycle arrest at various checkpoints -Angiogenesis Inhibition Caffeic acid typically shows low oral bioavailability (sometimes only a few percent of the ingested dose is systemically available) and a short plasma half-life (around 1–2 hours in animal models). |
| 1011- | CA, | Dihydrocaffeic acid improves IL-1β-induced inflammation and cartilage degradation via inhibiting NF-κB and MAPK signalling pathways |
| - | in-vivo, | NA, | NA |
| 1207- | CA, | PacT, | Caffeine inhibits the anticancer activity of paclitaxel via down-regulation of α-tubulin acetylation |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Cerv, | HeLa |
| 1230- | CA, | Caff, | Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 | - | Human, | NA, | NA |
| 1297- | CA, | Caffeic Acid Phenethyl Ester (CAPE) Induced Apoptosis in Serous Ovarian Cancer OV7 Cells by Deregulation of BCL2/BAX Genes |
| - | in-vitro, | Ovarian, | OV7 |
| - | in-vitro, | Cerv, | SiHa |
| 1646- | CA, | Caffeic acid: a brief overview of its presence, metabolism, and bioactivity |
| - | Review, | Nor, | NA |
| 1650- | CA, | Adjuvant Properties of Caffeic Acid in Cancer Treatment |
| - | Review, | Var, | NA |
| 1651- | CA, | PBG, | Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer |
| - | Review, | Var, | NA |
| 1652- | CA, | Caffeic Acid and Diseases—Mechanisms of Action |
| - | Review, | Var, | NA |
| 2399- | CA, | EA, | Polyphenol-rich diet mediates interplay between macrophage-neutrophil and gut microbiota to alleviate intestinal inflammation |
| - | Review, | Col, | NA |
| - | Analysis, | AD, | NA |
| - | Study, | AD, | NA |
| 3791- | CA, | Caffeic Acid and Diseases—Mechanisms of Action |
| - | Review, | AD, | NA |
| 4342- | CA, | Antiplatelet effects of caffeic acid due to Ca(2+) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation |
| - | in-vitro, | NA, | NA |
| 1647- | PBG, | CA, | Antioxidant Properties and Phenolic Composition of Greek Propolis Extracts |
| - | Analysis, | Nor, | NA |
| 380- | SNP, | QC, | CA, | Chit, | Quercetin- and caffeic acid-functionalized chitosan-capped colloidal silver nanoparticles: one-pot synthesis, characterization, and anticancer and antibacterial activities |
| - | in-vitro, | MG, | U118MG |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:51 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid